Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Edoxaban”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03395639
What this trial is testing

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Who this might be right for
Cardiac Disease
Daiichi Sankyo 168
Not applicableUnknownNCT06431789
What this trial is testing

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Who this might be right for
Gene PolymorphismEdoxabanRenal Insufficiency
Yi Han 220
Large-scale testing (Phase 3)UnknownNCT03570281
What this trial is testing

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)

Who this might be right for
Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
Samsung Medical Center 40
Not applicableStudy completedNCT02943993
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2,809
Post-approval studies (Phase 4)Looking for participantsNCT07753200
What this trial is testing

Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease

Who this might be right for
Atrial Fibrillation (AF)Coronary Arterial Disease (CAD)
Samsung Medical Center 3,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT06149533
What this trial is testing

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients

Who this might be right for
Thrombosis, VenousCancerCatheter Complications
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 366
Large-scale testing (Phase 3)Study completedNCT05122455
What this trial is testing

Effects of Edoxaban on Platelet Aggregation

Who this might be right for
SCADAMI
University of Sao Paulo 61
Testing effectiveness (Phase 2)Study completedNCT03433235
What this trial is testing

Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Acute Ischemic Stroke
Jong Sung Kim 68
Large-scale testing (Phase 3)Study completedNCT02943785
What this trial is testing

Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 1,426
Not applicableStudy completedNCT05262322
What this trial is testing

Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company 234
Not applicableNot Yet RecruitingNCT07116239
What this trial is testing

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeHypoalbuminemia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03489395
What this trial is testing

A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Raffaele De Caterina 25
Not applicableStudy completedNCT03488420
What this trial is testing

Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

Who this might be right for
Atrial Fibrillation and FlutterValvular Heart Disease
Montreal Heart Institute 136
Not applicableStudy completedNCT06930937
What this trial is testing

To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions

Who this might be right for
Prevention of Stroke or Systemic EmbolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)
Humanis Saglık Anonim Sirketi 42
Not applicableStudy completedNCT02952599
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo 352
Not applicableNot Yet RecruitingNCT06864052
What this trial is testing

The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation

Who this might be right for
StrokeAtrial Fibrillation
Ewha Womans University Seoul Hospital 400
Not applicableUnknownNCT02448901
What this trial is testing

Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

Who this might be right for
Heart Failure
LifeBridge Health 40
Not applicableStudy completedNCT04519944
What this trial is testing

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Who this might be right for
Non-valvular Atrial Fibrillation
Daiichi Sankyo 666
Not applicableUnknownNCT04042155
What this trial is testing

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)

Who this might be right for
Atrial FibrillationRecurrent Venous Thromboembolism
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,600
Testing effectiveness (Phase 2)Study completedNCT01802775
What this trial is testing

Edoxaban in Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Daiichi Sankyo 203
Next Page